in whole but not in part at any time within 90 days following a Regulatory Capital Treatment Event — see red EFTA00642847 Listing: None (TRACE) DRD/ODI eligible: Yes, see Red for tax and withholding details Use of Proceeds To repurchase up to $560 million of common stock, with a proportionate reduct